Pazopanib as Second-Line Treatment After Sunitinib or...

Clinical Genitourinary Cancer 2013 / 9 Vol. 11; Iss. 3

Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial

Hainsworth, John D., Rubin, Mark S., Arrowsmith, Edward R., Khatcheressian, James, Crane, Edward J., Franco, Luis A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2013.04.006
Date:
September, 2013
File:
PDF, 391 KB
english, 2013
Conversion to is in progress
Conversion to is failed